SCHEMBL1925183

SCHEMBL1925183

Cc1ccc(S(=O)(=O)/C=C/c2ccc([N+](=O)[O-])cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.56
HSD17B10 Q99714 2/20 0.56
MAOA P21397 1/20 0.55
MAOB P27338 1/20 0.55
TLR9 Q9NR96 1/20 0.55
NFE2L2 Q16236 1/20 0.51
APP P05067 1/20 0.50
FBP1 P09467 2/20 0.49
BCHE P06276 1/20 0.48
PTGS2 P35354 4/20 0.48
PTGS1 P23219 2/20 0.48
PKM P14618 1/20 0.47
RAB9A P51151 3/20 0.46
MAPT P10636 3/20 0.46
NPC1 O15118 2/20 0.46
KMT2A Q03164 2/20 0.46
HSP90AA1 P07900 1/20 0.46
CXCR5 P32302 1/20 0.46
APLNR P35414 1/20 0.46
CCR6 P51684 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4478513 1.00 ACHE (0.56) ACHEHSD17B10MAOAMAOBTLR9
SCHEMBL28343916 0.87 TLR9 (0.72) HSD17B10TLR9NFE2L2FBP1RAB9A
SCHEMBL28813938 0.84 CYP1B1 (0.53) MAOBNFE2L2APPFBP1BCHE
SCHEMBL27980282 0.84 CYP1B1 (0.53) MAOBNFE2L2APPFBP1BCHE
SCHEMBL31490968 0.84 MAPT (0.49) HSD17B10APPFBP1PTGS2PTGS1
SCHEMBL5514260 0.83 ACHE (0.75) ACHEHSD17B10MAOAMAOBNFE2L2
SCHEMBL2681912 0.83 ACHE (0.75) ACHEHSD17B10MAOAMAOBNFE2L2
SCHEMBL17589690 0.83 ACHE (0.75) ACHEHSD17B10MAOAMAOBNFE2L2
SCHEMBL1195202 0.80 ACHE (0.50) ACHEHSD17B10MAOAMAOBNFE2L2
SCHEMBL1195205 0.80 ACHE (0.50) ACHEHSD17B10MAOAMAOBNFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108623503-B Green preparation method of vinyl sulfone derivative in water phase 宁波大学 2020-01-03 CN disclosed
EP-1856043-B1 1-H-PYRROLE-2-CARBOXAMIDES AND IMIDAZOLE-5-CARBOXAMIDES AND USE THEREOF AS FAK, KDR AND TIE2 KINASE MODULATORS FOR THE TREATMENT OF CANCER AVENTIS PHARMA SA (FR) 2011-06-08 EP disclosed
US-7560571-B2 Substituted pyrroles and imidazoles, compositions containing same, manufacturing process therefor and use thereof AVENTIS PHARMA S.A. (FR) 2009-07-14 US disclosed
US-20080045542-A1 Substituted Pyrroles and Imidazoles, Compositions Containing Same, Manufacturing Process Therefor and Use Thereof AVENTIS PHARMA S.A. (FR) 2008-02-21 US disclosed
EP-1856043-A1 1-H-PYRROLE-2-CARBOXAMIDES AND IMIDAZOLE-5-CARBOXAMIDES AND USE THEREOF AS FAK, KDR AND TIE2 KINASE MODULATORS FOR THE TREATMENT OF CANCER Aventis Pharma S.A. (FR) 2007-11-21 EP disclosed
WO-2006082309-A1 1-H-PYRROLE-2-CARBOXAMIDES AND IMIDAZOLE-5-CARBOXAMIDES AND USE THEREOF AS FAK, KDR AND TIE2 KINASE MODULATORS FOR THE TREATMENT OF CANCER AVENTIS PHARMA SA (FR) 2006-08-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080045542-A1 Substituted Pyrroles and Imidazoles, Compositions Containing Same, Manufacturing Process Therefor and Use Thereof WEE1, WEE2, FARS2 ACHE 4487/4885HSD17B10 4447/4885MAOA 3414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.